Context Therapeutics Inc (CNTX)
NASDAQ
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -40.763 | -34.358 | -88.708 |
Return on Equity (%) | -43.325 | -36.941 | -102.786 |
Return on Invested Capital (%) | -43.657 | -38.297 | -107.619 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 1.512 | 2.177 | 0.744 |
Earnings Per Share | -0.327 | -0.961 | -1.501 |
Cash Per Share | 1.554 | 2.223 | 0.905 |
Working Capital Per Share | 1.51 | 2.17 | 0.743 |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | -0.327 | -0.96 | -1.501 |
EBITDA Per Share | -0.327 | -0.96 | -1.501 |
Free Cash Flow Per Share | -0.327 | -0.959 | -1.502 |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
Current Ratio | 16.894 | 11.8 | 3.828 |
Quick Ratio | 16.36 | 11.065 | 3.447 |
Inventory Turnover (Days) | N/A | N/A | N/A |
Shares Outstanding | 15.97M | 15.97M | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | ||||||
Shares Outstanding | 15.97M | 15.97M | 15.97M | N/A | 15.97M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 9.863 | N/A | N/A | N/A | 4.231 |
Quick Ratio | N/A | N/A | N/A | 9.208 | N/A | N/A | N/A | 3.867 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 183M |
Price to Earnings Ratio | -7.82 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 12.97 |
Price to Book Ratio | 15.79 |
Dividend Yield | - |
Shares Outstanding | 75M |
Average Volume (1 week) | 80.95k |
Average Volume (1 Month) | 96.33k |
52 Week Change | 135.85% |
52 Week High | 2.54 |
52 Week Low | 0.77 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.